| Management number | 237100772 | Release Date | 2026/07/10 | List Price | US$6.98 | Model Number | 237100772 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Thrombocythemia is a medical condition characterized by an abnormally high platelet count in the blood. Platelets, also known as thrombocytes, are small blood cells that help with clotting. When an injury occurs, platelets gather at the site to form a clot and prevent excessive bleeding. However, when platelet levels are too high, there is an increased risk of blood clot formation, which can lead to serious complications such as stroke, heart attack, or deep vein thrombosis (DVT).Thrombocythemia can be primary (essential thrombocythemia, ET) or secondary (reactive thrombocytosis). Understanding the causes, symptoms, and risks associated with this condition is essential for managing it effectively.What is Thrombocythemia?Thrombocythemia is a disorder where the bone marrow produces too many platelets. Normally, platelet levels range between 150,000 to 450,000 platelets per microliter of blood. A count above 450,000 platelets per microliter is considered thrombocytosis, and a count exceeding 1,000,000 platelets per microliter is classified as severe.While having a high platelet count might not always cause symptoms, it increases the risk of abnormal blood clotting (thrombosis) or, paradoxically, excessive bleeding due to dysfunctional platelets.There are two main types of thrombocythemia:1. Essential Thrombocythemia (ET) or Primary Thrombocythemia – A chronic blood disorder where the bone marrow overproduces platelets due to genetic mutations.2. Secondary (Reactive) Thrombocytosis – A condition where elevated platelet counts occur as a reaction to another underlying issue, such as infection or inflammation.Types and Causes of Thrombocythemia1. Essential Thrombocythemia (ET) – Primary ThrombocythemiaEssential thrombocythemia is a myeloproliferative disorder, meaning it results from an abnormality in the bone marrow that leads to excessive platelet production. It is considered a chronic condition and is not caused by an external factor like infection or inflammation.Causes:● Genetic Mutations – In most cases, ET is linked to mutations in genes responsible for blood cell production, including:○ JAK2 (Janus kinase 2) mutation – Found in about 50-60% of ET cases.○ CALR (Calreticulin) mutation – Present in 15-25% of cases.○ MPL (Myeloproliferative leukemia virus oncogene) mutation – Found in 3-5% of cases.● Unknown Factors – In some cases, no specific genetic mutation is detected, but abnormal platelet production persists.2. Secondary (Reactive) ThrombocytosisThis form of thrombocytosis is caused by an underlying medical condition, which triggers the body to produce more platelets as a reaction. Unlike ET, reactive thrombocytosis does not originate from bone marrow abnormalities.Common Causes of Secondary Thrombocythemia:● Inflammatory Diseases – Conditions such as rheumatoid arthritis, inflammatory bowel disease (IBD), or lupus can stimulate the bone marrow to produce more platelets.● Infections – Chronic or severe infections (bacterial, viral, or fungal) may trigger an increase in platelet production.● Iron Deficiency – Low iron levels in the blood can lead to increased platelet counts, though the mechanism is not fully understood.● Cancer – Some cancers, including lung, breast, and ovarian cancer, can cause elevated platelet levels as part of the body's response to the disease.● Splenectomy (Spleen Removal) – The spleen plays a role in regulating platelets. After spleen removal, platelet counts often rise.● Surgery or Trauma – The body may react to surgical procedures or severe injuries by producing more platelets.● Medications – Certain drugs, such as corticosteroids or epinephrine, can increase platelet counts. Read more
| ASIN | B0FBM71KF8 |
|---|---|
| ISBN13 | 979-8285978886 |
| Language | English |
| Publisher | Independently published |
| Dimensions | 6 x 0.48 x 9 inches |
| Item Weight | 13.6 ounces |
| Print length | 213 pages |
| Publication date | May 31, 2025 |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form